These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30508885)

  • 1. Clinicopathological and prognostic significance of GLUT1 in breast cancer: A meta-analysis.
    Deng Y; Zou J; Deng T; Liu J
    Medicine (Baltimore); 2018 Nov; 97(48):e12961. PubMed ID: 30508885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
    PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis.
    Jiang D; Gao Z; Cai Z; Wang M; He J
    BMC Cancer; 2015 Oct; 15():727. PubMed ID: 26475790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Qiao W; Liu H; Guo W; Li P; Deng M
    Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High lncSNHG15 expression may predict poor cancer prognosis: a meta-analysis based on the PRISMA and the bio-informatics analysis.
    Fang SX; Chen C; Guo Q; Ke XX; Lu HL; Xu G
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.
    Xu F; Li M; Zhang C; Cui J; Liu J; Li J; Jiang H
    Oncotarget; 2017 Jan; 8(4):6003-6012. PubMed ID: 27999206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
    Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
    Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.
    Yu M; Yongzhi H; Chen S; Luo X; Lin Y; Zhou Y; Jin H; Hou B; Deng Y; Tu L; Jian Z
    Oncotarget; 2017 Jun; 8(26):43356-43367. PubMed ID: 28498810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
    Pan F; Mao H; Deng L; Li G; Geng P
    Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
    Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
    Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
    Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L
    Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
    Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
    Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis.
    Liu Y; Lv DL; Duan JJ; Xu SL; Zhang JF; Yang XJ; Zhang X; Cui YH; Bian XW; Yu SC
    BMC Cancer; 2014 Jun; 14():444. PubMed ID: 24938375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis.
    Zhang Y; Tian J; Qu C; Tang Z; Wang Y; Li K; Yang Y; Liu S
    Medicine (Baltimore); 2020 Dec; 99(49):e23359. PubMed ID: 33285715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
    Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
    World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
    Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
    Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
    Wu SW; Ma CC; Li WH
    Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and clinicopathological significance of blood vessel invasion in operable breast cancer: a systematic review and meta-analysis.
    Lin Y; Zhang Y; Fang H; Hu Q; Duan H; Zhang L; Pang D
    Jpn J Clin Oncol; 2023 Jan; 53(1):35-45. PubMed ID: 36156086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.